SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making
4 references·13 citing·39 second hop
The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004)The CORE Diabetes Model: Projecting Long-…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…One Thousand Health-Related Quality-of-Life Estimates (2000)One Thousand Health-Related Q…Markov Models in Medical Decision Making (1993)Markov Models in Medical Deci…Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Probabilistic Sensitivity Ana…Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation (2019)Estimating Quality of Life De…The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes (2016)The Cost-Effectiveness of Rea…Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050 (2016)Current and future economic b…Review of Utility Values for Economic Modeling in Type 2 Diabetes (2014)Review of Utility Values for …A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation (2011)A meta-analysis of health sta…Utilities and disutilities for attributes of injectable treatments for type 2 diabetes (2010)Utilities and disutilities fo…Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin (2009)Cost-effectiveness of self-mo…Cost-effectiveness of insulin analogues for diabetes mellitus (2009)Cost-effectiveness of insulin…Utilities and disutilities for type 2 diabetes treatment-related attributes (2007)Utilities and disutilities fo…Estimating the Cost of Complications of Diabetes in Australia Using Administrative Health-Care Data (2007)Estimating the Cost of Compli…Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations (2007)Cost‐Effectiveness of Diabete…Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain (2005)Review of the cost of diabete…Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster) (2005)Evaluation of the costs and o…Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Judgment under Uncertainty: Heuristics and Biases (1974)Clinical Decision Analysis (1980)Handling Uncertainty in Cost-Effectiveness Models (2000)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)The Impact of 29 Chronic Conditions on Health-related Quality of Life: A General Population Survey in Finland Using 15D and EQ-5D (2006)A review of health utilities using the EQ-5D in studies of cardiovascular disease (2010)El coste de la diabetes tipo 2 en España. El estudio CODE-2 (2002)Economic Costs of Diabetes in the U.S. in 2002 (2003)Modelling EuroQol health‐related utility values for diabetic complications from CODE‐2 data (2004)The costs of treating long-term diabetic complications in a developing country: a study from India. (2013)Measuring Health: A Guide to Rating Scales and Questionnaires (1987)Methods for the Economic Evaluation of Health Care Programmes (2005)Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom (2008)The Effect of Hypoglycemia on Health-Related Quality of Life: Canadian Results from a Multinational Time Trade-off Survey (2014)Methods for the economic evaluation of health care programmes (1987)Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review (2013)Preference for pharmaceutical formulation and treatment process attributes (2016)Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations (2021)A study of the quality of life and cost-utility of renal transplantation (1996)Modeling Valuations for EuroQol Health States (1997)US Valuation of the EQ-5D Health States (2005)Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study (2015)“Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom (2020)The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review (2020)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)An Introduction to Markov Modelling for Economic Evaluation (1998)Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in the U.S. in 2012 (2013)Fully international system of units-traceable glycated hemoglobin quantification using two stages of isotope-dilution high-performance liquid chromatography–tandem mass spectrometry (2017)A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia (2020)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 1993Markov Models in Medical Decision Making2,411 cited
  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,170 cited
  • 1985Probabilistic Sensitivity Analysis Using Monte Carlo Simulation860 cited
  • 2000One Thousand Health-Related Quality-of-Life Estimates662 cited

Cited by

  • 2014Review of Utility Values for Economic Modeling in Type 2 Diabetes256 cited
  • 2010Utilities and disutilities for attributes of injectable treatments for type 2 diabetes139 cited
  • 2005Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain128 cited
  • 2009Cost-effectiveness of insulin analogues for diabetes mellitus116 cited
  • 2007Utilities and disutilities for type 2 diabetes treatment-related attributes115 cited
  • 2016Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050108 cited
  • 2005Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)88 cited
  • 2007Estimating the Cost of Complications of Diabetes in Australia Using Administrative Health-Care Data84 cited
  • 2007Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations82 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2016The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes81 cited
  • 2019Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation81 cited
  • 2011A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation70 cited
  • 2009Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin66 cited